Donate
Australian & New Zealand Childrens Haematology/Oncology Group

ANZCHOG Children’s Cancer Clinical Trials Repository

Study Title
International Randomised Phase III Clinical Trial in Children with Acute Myeloid Leukaemia – Incorporating an Embedded Dose Finding Study for Gemtuzumab Ozogamicin in Combination with Induction Chemotherapy
Protocol ID
RG_14-088 (MyeChild-01)
Disease (Sub Disease)
Leukaemia (AML)
Diagnosis Stage
New diagnosis
Location
NSW, QLD, VIC, WA, SA, NZ
Sponsor
Australian and New Zealand Children's Haematology Oncology Group
University of Birmingham
Collaborators
Assistance Publique - Hôpitaux de Paris
Cancer Research UK
National Cancer Institute, France
Pfizer
Trial Status
Open
Sites
The Children's Hospital at Westmead
John Hunter Children's Hospital
Monash Children's Hospital
Perth Children's Hospital
Queensland Children's Hospital
Sydney Children's Hospital
Royal Children's Hospital
Women's & Children's Hospital
Christchurch Hospital
Starship Hospital
Study Type
Treatment
Phase
Phase 3
Age Eligibility
up to 18 years
International registry ID's
NCT02724163
Back to Registry
Study Title International Randomised Phase III Clinical Trial in Children with Acute Myeloid Leukaemia – Incorporating an Embedded Dose Finding Study for Gemtuzumab Ozogamicin in Combination with Induction Chemotherapy
Protocol ID RG_14-088 (MyeChild-01)
Disease (Sub Disease) Leukaemia (AML)
Diagnosis Stage New diagnosis
Location NSW / QLD / VIC / WA / SA / NZ
Sponsor Australian and New Zealand Children's Haematology Oncology Group/ University of Birmingham
Collaborators Assistance Publique - Hôpitaux de Paris/ Cancer Research UK/ National Cancer Institute, France/ Pfizer
Links https://clinicaltrials.gov/ct2/show/NCT02724163
Trial Status Open
Trial Open Date 04/07/2018
Sites The Children's Hospital at Westmead / John Hunter Children's Hospital / Monash Children's Hospital / Perth Children's Hospital / Queensland Children's Hospital / Sydney Children's Hospital / Royal Children's Hospital / Women's & Children's Hospital / Christchurch Hospital / Starship Hospital
Study Type Treatment
Phase Phase 3
Age Eligibility up to 18 years
International registry ID's NCT02724163